SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Clinical Stage Biotechnology Companysynactpharma.com
Yleiskatsaus
- 5–9
- Työntekijät
- 5–10milj SEK
- Liikevaihto
- 2016
- Perustettu
Avainpäättäjät
Ann Kristin Led
Chief Financial Officer
@synactpharma.com+45311XXXXX
Jeppe Øvlesen
Chief Executive Officer
@synactpharma.com+45284XXXXX
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...